Production (Stage)
Innoviva, Inc.
INVA
$21.68
$0.100.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.83M | 29.29M | 32.45M | 36.16M | 19.08M |
| Total Other Revenue | 57.81M | 62.52M | 57.06M | 63.74M | 58.42M |
| Total Revenue | 88.63M | 91.81M | 89.51M | 99.90M | 77.50M |
| Cost of Revenue | 12.99M | 18.83M | 10.08M | 11.03M | 8.01M |
| Gross Profit | 75.64M | 72.97M | 79.42M | 88.87M | 69.49M |
| SG&A Expenses | 27.49M | 31.33M | 26.22M | 27.74M | 30.41M |
| Depreciation & Amortization | 6.48M | 6.51M | 6.51M | 6.44M | 6.44M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.96M | 46.95M | 46.27M | 45.21M | 44.85M |
| Operating Income | 41.67M | 44.86M | 43.24M | 54.69M | 32.65M |
| Income Before Tax | -38.59M | 24.69M | 6.85M | -39.28M | 45.12M |
| Income Tax Expenses | 8.00M | 4.36M | 5.64M | -4.59M | 8.59M |
| Earnings from Continuing Operations | -46.58M | 20.33M | 1.21M | -34.69M | 36.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.58M | 20.33M | 1.21M | -34.69M | 36.53M |
| EBIT | 41.67M | 44.86M | 43.24M | 54.69M | 32.65M |
| EBITDA | 48.18M | 51.40M | 49.77M | 61.15M | 39.14M |
| EPS Basic | -0.74 | 0.32 | 0.02 | -0.55 | 0.58 |
| Normalized Basic EPS | 0.40 | 0.46 | 0.42 | 0.51 | 0.30 |
| EPS Diluted | -0.74 | 0.28 | 0.02 | -0.55 | 0.46 |
| Normalized Diluted EPS | 0.40 | 0.34 | 0.42 | 0.51 | 0.22 |
| Average Basic Shares Outstanding | 62.71M | 62.63M | 62.57M | 62.53M | 63.19M |
| Average Diluted Shares Outstanding | 62.71M | 84.20M | 62.95M | 62.53M | 84.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |